Safeplus International Holdings Ltd. (ACAI)

[PowerPole]

NEWS: Source: Biophan Technologies, Inc.

Biophan's CEO Pens Column for Nanotech Briefs Magazine, Discusses Convergence of Nanotechnology and Biotechnology
Thursday March 3, 6:00 am ET
Highlights Include Breakthroughs in Healthcare Enabled by Nanotechnology


ROCHESTER, N.Y.--(BUSINESS WIRE)--March 3, 2005-- Biophan Technologies, Inc. (OTCBB:BIPH - News), a developer of next-generation biomedical technology, has announced the availability of an article authored by the Company CEO, Michael Weiner, in the January 2005 edition of Nanotech Briefs, an industry publication that focuses on nanotechnology and its applications. The article appears in the issue's "Perspective" column, and is entitled "The Convergence of Biotechnology and Nanotechnology."

In the article, Mr. Weiner discusses the accelerating progress in medical and technical knowledge that has come as a result of the convergence of the two disciplines of biotechnology and nanotechnology, in combination with other advances during the past 30 years.

"Miraculous breakthroughs will soon abound as a result of the overlapping and accelerating knowledge and innovation explosions as nanotechnology and biotechnology converge," Mr. Weiner writes.

Mr. Weiner cites authorities such as Andrew C. Von Eschenbach, M.D., Director of the U.S. Department of Health & Human Services of the National Institutes of Health, who has said that innovation in nanotechnology can bring an end to cancer by 2015.

Mr. Weiner adds malaria, heart disease, and diabetes to the list of serious diseases that nanotechnology can help combat. In addition, he writes, nanotechnology is contributing significantly to the battle against emerging potential health threats, such as the evolution of new viruses or bio-weapons.

The piece can be read in its entirety on the Biophan website, at www.biophan.com/NB_Perspective_0105.pdf.